Ankylosing spondylitis: statins reduce all-cause mortality by 37%

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
  • In patients with ankylosing spondylitis (AS), statin initiation was associated with a 37% reduction in all-cause mortality, independent of age, sex, BMI, socioeconomic status, relevant comorbidities, cardiovascular medication use, total cholesterol levels, and healthcare utilisation.